Why Choose NorthEast BioLab For Bioanalysis & ADME Studies?

The ADME assays are conducted to make a go-no-go decision regarding drug candidate selection and movement into late-stage preclinical and clinical programs. Regular improvements in the ADME properties are achieved during lead optimization while keeping the selectivity and potency of the chemical drug lead intact. It, however, is plausible to have chemically efficacious compounds with acceptable ADME properties but decreased in vivo potencies.

ADME studies form an efficacy benchmark for various drug compounds. The evaluation of these pharmacological properties is critical for the selection of a new drug candidate during drug discovery and development.Adme assay is used for evaluation of the physicochemical properties and bioavailability of drug compounds. The analysis comprises the absorption, distribution, metabolism and excretion of a drug after administration to the body. This forms an essential part during drug discovery and development and helps in decision making regarding the efficacy benchmark of a drug candidate.

ADME studies are conducted to assess the absorption, distribution, metabolism, and excretion (ADME) of a drug candidate. ADME compatibility helps in the drug discovery process by determining the rate of absorption and bioavailability from your drug candidate. The result of these experiments will provide you with a better understanding of how your compound is transported through biological fluids.

ADME assays are implemented to make a go-no-go decision regarding drug candidate selection and movement into late-stage preclinical and clinical programs. Regular improvements in the adme properties are achieved during lead optimization while keeping the selectivity and potency of the chemical drug lead intact. It, however, is plausible to have chemically efficacious compounds with acceptable ADME properties but decreased in vivo potencies.

NorthEast BioLab provides bioanalytical services to customers in the drug discovery, biopharmaceutical, and pharmaceutical industries. Our team has an excellent track record of advancing Pharmacokinetics (PK), Bioavailability and Bioequivalence (BA/BE), Toxicokinetics (TK), Immunogenicity (ADA), Biomarker Testing, and Custom Assays. We are GLP/GCLP compliant and FDA audited, DEA & CT State Schedule II-IV approved facility.NorthEast BioLab is a bioanalytical lab with 15+ years experience in providing small and large molecule bioanalysis for clinical, preclinical, and drug discovery studies. Our team has an excellent track record of advancing Pharmacokinetics (PK), Bioavailability and Bioequivalence (BA/BE), Toxicokinetics (TK), Immunogenicity (ADA), Biomarker Testing, and Custom Assays.

NorthEast biolab provides small and large molecule bioanalysis for clinical, preclinical, and drug discovery studies. Our team has an excellent track record of advancing Pharmacokinetics (PK), Bioavailability and Bioequivalence (BA/BE), Toxicokinetics (TK), Immunogenicity (ADA), Biomarker Testing, and Custom Assays.

Biolab provides high-quality bioanalytical services to the pharmaceutical, biotechnology and medical device industries. We have a wide variety of capabilities in a state-of-the-art facility that is GLP (Good Laboratory Practices), FDA audited and DEA/CT State Schedule II-IV approved.

We are the leading clinical research specialties lab focusing on Pharmacokinetics, Bioavailability and Bioequivalence, Toxicokinetics, Custom Assays and other assay development. Our quality of services is top notch across the board. We offer our customers access to leading edge technologies such as LC-MS/MS, ELISA, MSD ECL, Luminex Multiplex, Western Blot and qPCR at highly competitive rates.

By jessicaadison010

Leave a Reply

Your email address will not be published.

You May Also Like